ATE384701T1 - Isochinolinone als kalium-kanal-inhibitoren - Google Patents

Isochinolinone als kalium-kanal-inhibitoren

Info

Publication number
ATE384701T1
ATE384701T1 AT01981316T AT01981316T ATE384701T1 AT E384701 T1 ATE384701 T1 AT E384701T1 AT 01981316 T AT01981316 T AT 01981316T AT 01981316 T AT01981316 T AT 01981316T AT E384701 T1 ATE384701 T1 AT E384701T1
Authority
AT
Austria
Prior art keywords
present
arrhythmias
currents
isoquinolinones
pharmaceutically acceptable
Prior art date
Application number
AT01981316T
Other languages
English (en)
Inventor
David Claremon
Charles Mcintyre
Nigel Liverton
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE384701T1 publication Critical patent/ATE384701T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
AT01981316T 2000-09-20 2001-09-17 Isochinolinone als kalium-kanal-inhibitoren ATE384701T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23438900P 2000-09-20 2000-09-20

Publications (1)

Publication Number Publication Date
ATE384701T1 true ATE384701T1 (de) 2008-02-15

Family

ID=22881180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981316T ATE384701T1 (de) 2000-09-20 2001-09-17 Isochinolinone als kalium-kanal-inhibitoren

Country Status (8)

Country Link
US (1) US6870055B2 (de)
EP (1) EP1322619B1 (de)
JP (1) JP4854909B2 (de)
AT (1) ATE384701T1 (de)
AU (2) AU1296902A (de)
CA (1) CA2421819C (de)
DE (1) DE60132606T2 (de)
WO (1) WO2002024655A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400058A2 (hu) 2001-02-02 2004-04-28 Takeda Chemical Industries, Ltd. Kondenzált heterogyűrűs vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
EP1667978B1 (de) * 2003-09-23 2013-09-04 Merck Sharp & Dohme Corp. Isochinolinon-Kaliumkanalinhibitoren
AU2004276237B2 (en) * 2003-09-23 2008-08-21 Merck Sharp & Dohme Corp. Quinoline potassium channel inhibitors
WO2005030727A1 (en) 2003-09-23 2005-04-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
WO2005030726A1 (en) 2003-09-23 2005-04-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
JP4719681B2 (ja) 2003-09-23 2011-07-06 メルク・シャープ・エンド・ドーム・コーポレイション キナゾリンカリウムチャネル阻害剤
US7723352B2 (en) 2003-09-23 2010-05-25 Merck Sharp & Dohme Isoquinolinone potassium channel inhibitors
CA2539546C (en) * 2003-09-23 2010-07-13 Merck & Co., Inc. Isoquinoline potassium channel inhibitors
WO2005030129A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Quinoline potassium channel inhibitors
WO2005061460A1 (en) * 2003-12-08 2005-07-07 Cytokinetics, Inc. Compounds, compositions, and methods
GB0412986D0 (en) 2004-06-10 2004-07-14 Xention Discovery Ltd Compounds
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
US7879839B2 (en) 2004-07-29 2011-02-01 Merck Sharp & Dohme Corp. Potassium channel inhibitors
AU2005269505B2 (en) 2004-07-29 2011-06-16 Merck Sharp & Dohme Corp. Potassium channel inhibitors
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
EP1909572A4 (de) 2005-07-22 2010-09-08 Merck Sharp & Dohme Kaliumkanalinhibitoren
US8148535B2 (en) * 2005-10-21 2012-04-03 Merck Sharp & Dohme Corp. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
WO2007089743A2 (en) 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
WO2007089735A2 (en) 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
US11477617B2 (en) * 2006-03-20 2022-10-18 Ericsson Evdo Inc. Unicasting and multicasting multimedia services
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
EP2647376A1 (de) 2007-01-22 2013-10-09 Gtx, Inc. Nuklearrezeptorbindende Wirkstoffe
US9623021B2 (en) * 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
WO2010130638A1 (en) * 2009-05-14 2010-11-18 Evotec Ag Sulfonamide compounds, pharmaceutical compositions and uses thereof
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (de) 2011-07-01 2018-04-28
AU2013203252B2 (en) 2012-01-27 2015-08-20 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2021012208A (es) 2013-10-04 2023-01-19 Infinity Pharmaceuticals Inc Compuestos heterocíclicos y usos de los mismos.
CA2943075C (en) 2014-03-19 2023-02-28 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
US10874787B2 (en) 2014-12-10 2020-12-29 Medtronic, Inc. Degassing system for dialysis
US10160761B2 (en) 2015-09-14 2018-12-25 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE528489A (de) * 1953-04-29
ATE124408T1 (de) 1990-10-16 1995-07-15 Takeda Chemical Industries Ltd Heterozyklische aminderivate, deren herstellung und deren verwendung.
ATE161530T1 (de) * 1992-09-04 1998-01-15 Takeda Chemical Industries Ltd Kondensierte heterozyklische verbindungen, deren herstellung und verwendung
JP3724818B2 (ja) * 1992-09-04 2005-12-07 武田薬品工業株式会社 縮合複素環化合物、その製造法および剤
EP0634402A1 (de) * 1993-07-14 1995-01-18 Takeda Chemical Industries, Ltd. Isochinolinon-Derivate, ihre Herstellung und Verwendung
JPH0776573A (ja) * 1993-07-14 1995-03-20 Takeda Chem Ind Ltd ヘテロ環化合物、その製造法および剤
DE9310530U1 (de) 1993-07-15 1993-09-09 Ke Rohrsysteme Umwelttech Wärmeisoliertes Leitungsrohr
WO1998038168A1 (en) * 1997-02-27 1998-09-03 Tanabe Seiyaku Co., Ltd. Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
JPH10298164A (ja) * 1997-02-27 1998-11-10 Tanabe Seiyaku Co Ltd イソキノリノン誘導体、その製法及びその合成中間体
AU7696098A (en) * 1997-08-11 1999-03-01 Algos Pharmaceutical Corporation Substance p inhibitors in combination with nmda-blockers for treating pain
JP2000072675A (ja) * 1998-08-26 2000-03-07 Tanabe Seiyaku Co Ltd 医薬組成物
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors

Also Published As

Publication number Publication date
EP1322619A4 (de) 2004-02-25
DE60132606T2 (de) 2009-02-19
JP2004509868A (ja) 2004-04-02
US20040044030A1 (en) 2004-03-04
CA2421819A1 (en) 2002-03-28
DE60132606D1 (de) 2008-03-13
EP1322619B1 (de) 2008-01-23
US6870055B2 (en) 2005-03-22
CA2421819C (en) 2010-03-09
AU1296902A (en) 2002-04-02
EP1322619A1 (de) 2003-07-02
WO2002024655A1 (en) 2002-03-28
AU2002212969B2 (en) 2006-07-06
JP4854909B2 (ja) 2012-01-18

Similar Documents

Publication Publication Date Title
ATE384701T1 (de) Isochinolinone als kalium-kanal-inhibitoren
AP9901478A0 (en) Compounds for the treatment of ischemia.
WO2001056989A3 (en) Inhibitors of factor xa
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
EA200101077A1 (ru) Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
ATE307119T1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
BG66087B1 (bg) Хинолинонови производни като тирозин киназни инхибитори
RS82003A (en) Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof
AP2000001889A0 (en) Substituted ozoazaheterocyclyl factor Xa inhibitors.
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
NO20003018L (no) Triazinangiogenese-inhibitorer
YU76401A (sh) 1-amino triazolo(4,3-a)hinazolin-5-oni i/ili - 5-tioni koji inhibiraju fosfodiesteraze iv
CY2472B1 (en) Substituted dihydrobenzofurans as pde inhibitors.
KR20000005379A (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
HK1033574A1 (en) Anitumor agents
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
WO2001072708A3 (en) OXINDOLE INHIBITORS OF FACTOR Xa
SI1274685T1 (sl) Derivat piridin-1-oksida in postopek njegove transformacije v farmacevtsko ucinkovite sestavine
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
DK0880520T3 (da) Benzo[c]quinolinderivater, deres fremstilling af anvendelse som 5-alfa-reduktaseinhibitorer
MXPA03004023A (es) Compuestos quimicos.
PT1276722E (pt) Inibidores de naftamidina-uroquinase
EA200300059A1 (ru) Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина, таксанов и/или антиметаболитов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties